高效合成倍半萜酿酒酵母的构建策略

倍半萜是具有较强香气和优良生物活性的萜类化合物,能用于香料、燃料和药物的合成。目前,工业上获取倍半萜的常见方法主要是化学合成以及植物提取。由于常见方法存在产率低、成本高和污染大等不可避免的问题,科研人员开始关注微生物合成倍半萜的相关研究,并且以酿酒酵母为宿主采用代谢工程、酶工程和合成生物学等方法构建了生产各种倍半萜的微生物细胞工厂。介绍和解析了酿酒酵母倍半萜合成途径。围绕乙酰辅酶A的积累、甲羟戊酸途径的强化和改造以及底物竞争途径的抑制三个方面,综述了改造和强化倍半萜合成途径的具体策略和相关实例。概述了近年来关于倍半萜合成酶的挖掘和突变研究进展。最后,针对如何进一步提高酿酒酵母合成倍半萜的效率提出展望与建议。     

挖掘与调控乙酸胁迫响应基因提高重组酿酒酵母合成番茄红素水平

【背景】乙酰辅酶A是酿酒酵母异源合成番茄红素的重要中间产物,胞质中乙酰辅酶A主要来自乙酰辅酶A合成酶催化乙酸合成。【目的】通过外源添加乙酸盐结合调控乙酸胁迫应答基因增加胞内乙酰辅酶A含量,改善细胞生长,促进番茄红素合成。【方法】在合成番茄红素的重组酵母菌中过表达乙酰辅酶A合成酶编码基因(acs2),在发酵过程中添加10g/L乙酸盐,结合转录组学分析挖掘乙酸胁迫响应基因,进行单一和组合调控。【结果】添加乙酸盐后,重组菌Y02中番茄红素含量增加了19.14%,但细胞生长受到抑制,转录组学结果表明adk2、fap7、hem13、elo3、pdc5、set5、pmt5、hst4、clb2和swe1表达水平增加,因此构建了单基因和双基因过表达菌株,其中Y02-set5-hst4菌在添加乙酸盐后细胞生长得到了显著改善,同时胞内乙酰辅酶A浓度提高了78.21%,番茄红素含量和产量达到12.62 mg/g-DCW和108.67 mg/L,与对照菌Y02相比分别提高了42.76%和67.13%。同时该菌中甲羟戊酸途径中关键基因erg12、erg20和hmg1的表达量与对照菌相比分别上调了1.70、1.4...     

酿酒酵母细胞器区室化合成化学品的研究进展

公认食品安全的酿酒酵母(Saccharomyces cerevisiae)是合成生物学中被广泛研究的底盘细胞,常作为生产高值或大宗化学品的微生物细胞工厂。近年来,通过各种代谢工程改造策略,已有大量化学品的合成途径在酿酒酵母中建立并优化,且部分化学品具备了产业化价值。作为真核生物,酿酒酵母具有完整的细胞内膜系统及其组成的复杂细胞器区室,而这些细胞器区室往往含有某些化学品合成所必需的较高浓度前体底物(如线粒体中的乙酰辅酶A),或更加充足的酶、辅因子、能量等,可为目标产物的生物合成提供更适宜的物理、化学环境,但同时不同细胞器的结构特点有时也成为特定化合物合成的障碍。为此,研究人员在深入分析不同细胞器自身特点的基础上,结合目标化学品合成途径与细胞器之间的适配度,对细胞器开展了大量针对性改造工作以提高产物合成效率。本文详细综述了酿酒酵母中线粒体、过氧化物酶体、高尔基体、内质网、脂滴和液泡等细胞器的途径改造及优化策略,以及利用细胞器区室化合成化学品的研究进展,并对目前存在的困难和挑战以及未来研究方向进行了总结与展望。     

构建酿酒酵母细胞工厂高效合成摩尔酸

[目的] 摩尔酸作为齐墩果烷型三萜化合物具有抗HIV、抗炎等多种生物学活性,其前体物质是计曼尼醇,本研究基于合成生物学策略构建酿酒酵母细胞工厂高效合成摩尔酸。[方法] 运用CRISPR/Cas9技术,首先分别整合不同来源的氧化鲨烯环化酶（OSCs）,筛选高产计曼尼醇底盘细胞;进一步异源表达长春花来源的细胞色素P450氧化酶（CYP716AL1）和麻风树来源的细胞色素P450还原酶（JcCPR）,构建摩尔酸生物合成途径;并通过CYP716AL1和不同来源的CPR适配研究以及过表达甲羟戊酸（MVA）代谢途径中关键酶的方式提高摩尔酸的产量。[结果] 整合苹果来源的氧化鲨烯环化酶MdOSC获得的重组菌株计曼尼醇产量最高,达68.3 mg/L;以此为底盘细胞进一步整合CYP716AL1和JcCPR实现了摩尔酸的生物合成,产量为15.0 mg/L;共表达CYP716AL1和拟南芥来源的CPR获得的重组菌株摩尔酸产量最高,达到24.3 mg/L;最后过表达MVA代谢途径中的关键酶法呢基焦磷酸合酶（ERG20）和鲨烯环氧酶（ERG1）,获得的重组菌株摩尔酸产量高达34.1 mg/L。[结论] 本研究实现了摩尔酸的高效生物合成,为构建高产齐墩果烷型三萜酿酒酵母细胞工厂提供了理论和技术依据。     

高效合成葡萄糖二酸酿酒酵母工程菌的构建

葡萄糖二酸是天然存在的一种重要二元酸,其在医疗保健和化工工业等领域具有很高的实际应用价值,因此被称为"最具价值的生物炼制产品之一".以酿酒酵母(Saccharomyces cerevisiae)为底盘微生物,文中考察了过量表达肌醇转运蛋白Itr1、融合表达肌醇加氧酶和葡萄糖醛酸脱氢酶以及弱化表达葡萄糖6-磷酸脱氢酶基因...     

酿酒酵母SNF4基因敲除缺失菌株的构建

构建一株酿酒酵母SNF4基因缺失菌株并研究其对乙醇产量的影响。扩增带有SNF4基因上下游同源序列和Kanr筛选标记的SNF4基因敲除组件,转化到酿酒酵母YS2获得阳性克隆子,然后将质粒pSH65转到阳性克隆子中,半乳糖诱导pSH65表达Cre酶切除Kanr筛选标记,获得SNF4等位基因完全缺失菌株YS2-△SNF4。发酵实验结果表明,缺失菌株YS2-△SNF4乙醇产量较出发菌株提高了7.57％。利用Cre-LoxP系统,成功构建了SNF4等位基因完全缺失菌株并提高乙醇产生量。     

Man8GlcNAc2糖基化的酿酒酵母菌株的构建

酿酒酵母糖蛋白的N-糖基化经过高尔基体的修饰后形成聚合度约150-200的甘露寡糖,高尔基体N-糖基化的糖基转移酶Mnn1p和Och1p在甘露寡糖的形成过程中起关键作用。通过同源重组置换敲除了酵母中的MNN1和OCH1基因阻断高尔基体N-糖基化修饰,分离纯化了mnn1 och1突变株中的N-糖蛋白,糖酰胺酶PNGaseF酶解释放的N-糖链经过2-氨基吡啶衍生后,利用HPLC和MALDITOF/MS结合的方法分析了突变株糖蛋白上的N-糖链。结果显示mnn1 och1突变株中的糖蛋白的N-糖链为结构单一的糖链,分子量为1794.66,推测为Man8GlcNAc2。     

产对香豆酸酿酒酵母工程菌株的构建与优化

对香豆酸是黄酮类、芪类等天然活性化合物的重要前体,在生物医药、食品等行业应用广泛。与传统植物提取和化学合成相比,微生物合成对香豆酸因其具有生产周期短、转化效率高等优势而得到广泛关注。为构建高产对香豆酸酵母工程菌株,以酿酒酵母为出发菌,通过敲除酪氨酸合成竞争路径基因ARO10和PDC5,突变芳香族氨基酸合成调控基因ARO4^K229L与ARO7^G141S、解除酪氨酸负反馈抑制、并整合酪氨酸解氨酶FjTAL,获得的工程菌C001对香豆酸产量为296.73 mg/L。为进一步提高对香豆酸合成前体积累,分别敲除8个与氨基酸、糖类等转运相关基因并强化糖异生途径,分析其对对香豆酸积累的影响。结果表明,敲除GAL2及过表达EcppsA,对香豆酸产量提高至475.11 mg/L。最后,分析了FjTAL蛋白锚定至酵母液泡对产物积累的影响,结果表明其定位液泡后对香豆酸产量明显提升,达到593.04mg/L。通过强化前体物供应,阻断竞争旁路途径,利用亚细胞定位等策略有效提高对香豆酸产量,为后续黄酮类及芪类化合物的合成提供高效平台菌株,具有重要的应用前景。     

可同化阿拉伯糖的木糖还原酿酒酵母菌株构建

[目的] 以秸秆等木质纤维素类生物质为原料生产液体生物燃料乙醇,目前生产成本高,大规模工业化生产尚有较大难度。构建能同化阿拉伯糖进行木糖还原生产木糖醇的重组酿酒酵母菌株,以实现原料中全糖利用、生产高附加值产品,实现产品多元化。[方法] 首先,利用CRISPR/Cas9基因编辑技术依次向出发菌株中导入阿拉伯糖代谢途径和木糖还原酶基因,使菌株获得代谢阿拉伯糖和将木糖转化为木糖醇的能力;其次,通过适应性驯化的进化工程手段,提高重组菌株对阿拉伯糖的利用效率;最后,通过混合糖发酵验证重组菌株利用阿拉伯糖和还原木糖产木糖醇的能力。[结果] 通过导入植物乳杆菌的阿拉伯糖代谢途径,酿酒酵母菌株获得了较好的利用阿拉伯糖生长繁殖的能力;进一步导入假丝酵母的木糖还原酶基因后,重组菌株在葡萄糖作为辅助碳源条件下可高效还原木糖产木糖醇,但阿拉伯糖的利用能力下降。利用以阿拉伯糖为唯一碳源的培养基进行反复批次驯化,阿拉伯糖的利用能力得以恢复和提升,得到表型较好的重组菌株KAX3-2。该菌株在木糖（50 g/L）和阿拉伯糖（20 g/L）混合糖发酵条件下发酵72 h时,对阿拉伯糖和木糖利用率分别达到42.1%和65.9%,木糖醇的收率为64%。[结论] 本研究成功构建了一株能有效利用阿拉伯糖并能将木糖转化为木糖醇的重组酿酒酵母菌株KAX3-2,为后续构建、获得阿拉伯糖代谢能力更强、木糖醇积累效率更高菌株的工作奠定了基础。     

菌体形态对发酵法生产番茄红素的影响

菌体形态是影响霉菌代谢的重要因素。主要考察了煤油和不同表面活性剂对三孢布拉氏霉菌菌体形态及番茄红素合成能力的影响。结果表明:当添加煤油和triton-X100形成菌丝球时,该菌丝形态不利于物质的传递,细胞合成番茄红素的能力无明显变化。而当添加水溶性表面活性剂span-20时,形成粗、短分散型的菌丝体,强化了传质,促进了番茄红素的合成,番茄红素生产能力提高了近3倍。     

产肌醇酿酒酵母基因工程菌的构建

【目的】过表达酿酒酵母肌醇合成关键酶基因INO1,促进肌醇合成,构建能够分泌肌醇的基因工程菌株。【方法】构建r DNA介导的INO1基因多拷贝整合表达载体p URIH,电转化酿酒酵母Y01菌株,构建工程菌株YI2-1和YI2-2,荧光定量PCR方法分析INO1基因表达量。敲除Kan MX抗性基因,HPLC检测重组菌发酵液中肌醇含量。【结果】获得INO1基因过表达菌株YI2-1和YI2-2,YI2-1的INO1基因表达量是出发菌Y01的16.235倍。敲除Kan MX抗性基因的菌株命名为YI2-1△KP,初步检测YI2-1△KP产肌醇量为627 mg/L。【结论】r DNA介导的INO1基因多拷贝整合表达载体p URIH能够有效地过表达目的基因;过表达菌株合成的肌醇不仅能满足自身的需要,而且能够向胞外分泌,具有潜在的工业应用价值。     

高效表达内切葡聚糖酶酿酒酵母工程菌的构建

内切葡聚糖酶 (EG) 是纤维素酶的重要组分,在纤维素降解酶系中发辉重要作用。由于天然微生物来源的内切葡聚糖酶产量低,极大地制约了其生产和应用,所以对内切葡聚糖酶进行高效异源表达是解决这一问题的有效途径。为了获得高效内切葡聚糖酶酿酒酵母工程菌,本研究从纤维梭菌中克隆了内切葡聚糖酶 (EG) 基因,全长1 996 bp,编码440个氨基酸,并与来源于酿酒酵母的PGK启动子序列、来源于pPIC9K质粒的α-信号肽序列以及来源于pSH65质粒的CYC1终止子序列通过重叠延伸PCR法构建完整表达盒 (PαEGC),通过整合rDNA的方法构建内切葡聚糖酶酿酒酵母的表达载体,在酿酒酵母中进行内切葡聚糖酶的随机多拷贝表达。利用微滴数字PCR鉴定内切葡聚糖酶拷贝数,并探索拷贝数与蛋白表达量之间的关系。通过rDNA整合法获得了拷贝数为1、3、4、7、9、11、15、16、19、21、22、23的内切葡聚糖酶酿酒酵母工程菌,结果表明当拷贝数为15时,酶活性最高,为351 U/mL。本研究成功构建了内切葡聚糖酶酿酒酵母工程菌,为其他工业酶异源高效表达提供参考和借鉴。     

Characterization of gamma-glutamylamidase-glutaminase activity in Saccharomyces cerevisiae

In a foregoing paper we have shown the presence in the yeast Saccharomyces cerevisiae of an enzyme catalyzing the hydrolysis of L-gamma-glutamyl-p-nitroanilide, but apparently distinct from gamma-glutamyltranspeptidase. The cellular level of this enzyme was not regulated by the nature of the nitrogen source supplied to the yeast cell. Purification was attempted, using ion exchange chromatography on DEAE Sephadex A 50, salt precipitations and successive chromatographies on DEAE Sephadex 6B and Sephadex G 100. The apparent molecular weight of the purified enzyme was 14,800 as determined by gel filtration. As shown by kinetic studies and thin layer chromatography, the enzyme preparation exhibited only hydrolytic activity against gamma-glutamylarylamide and L-glutamine with an optimal pH of about seven. Various gamma-glutamylaminoacids, amides, dipeptides and glutathione were inactive as substrates and no transferase activity was detected. The yeast gamma-glutamylarylamidase was activated by SH protective agents, dithiothreitol and reduced glutathione. Oxidized glutathione, ophtalmic acid and various gamma-glutamylaminoacids inhibited competitively the enzyme. The activity was also inhibited by L-gamma-glutamyl-o-(carboxy)phenylhydrazide and the couple serine-borate, both transition-state analogs of gamma-glutamyltranspeptidase. Diazooxonorleucine, reactive analog of glutamine, inactivated the enzyme. The physiological role of yeast gamma-glutamylarylamidase-glutaminase is still undefined but is most probably unrelated to the bulk assimilation of glutamine by yeast cells.     

Production of miltiradiene by metabolically engineered Saccharomyces cerevisiae

Metabolic engineering of microorganisms is an alternative and attractive route for production of valuable terpenoids that are usually extracted from plant sources. Tanshinones are the bioactive components of Salvia miltiorrhizha Bunge, which is a well‐known traditional Chinese medicine widely used for treatment of many cardiovascular diseases. As a step toward microbial production of tanshinones, copalyl diphosphate (CPP) synthase, and normal CPP kaurene synthase‐like genes, which convert the universal diterpenoid precursor geranylgeranyl diphosphate (GGPP) to miltiradiene (an important intermediate of the tanshinones synthetic pathway), was introduced into Saccharomyces cerevisiae, resulting in production of 4.2 mg/L miltiradiene. Improving supplies of isoprenoid precursors was then investigated for increasing miltiradiene production. Although over‐expression of a truncated 3‐hydroxyl‐3‐methylglutaryl‐CoA reductase (tHMGR) and a mutated global regulatory factor (upc2.1) gene did improve supply of farnesyl diphosphate (FPP), production of miltiradiene was not increased while large amounts of squalene (78 mg/L) were accumulated. In contrast, miltiradiene production increased to 8.8 mg/L by improving supply of GGPP through over‐expression of a fusion gene of FPP synthase (ERG20) and endogenous GGPP synthase (BTS1) together with a heterologous GGPP synthase from Sulfolobus acidocaldarius (SaGGPS). Auxotrophic markers in the episomal plasmids were then replaced by antibiotic markers, so that engineered yeast strains could use rich medium to obtain better cell growth while keeping plasmid stabilities. Over‐expressing ERG20‐BTS1 and SaGGPS genes increased miltiradiene production from 5.4 to 28.2 mg/L. Combinatorial over‐expression of tHMGR‐upc2.1 and ERG20‐BTS1‐SaGGPS genes had a synergetic effects on miltiradiene production, increasing titer to 61.8 mg/L. Finally, fed‐batch fermentation was performed, and 488 mg/L miltiradiene was produced. The yeast strains engineered in this work provide a basis for creating an alternative way for production of tanshinones in place of extraction from plant sources. Biotechnol. Bioeng. 2012; 109: 2845–2853. © 2012 Wiley Periodicals, Inc.     

Fermentative production of L-glycerol 3-phosphate utilizing a Saccharomyces cerevisiae strain with an engineered glycerol biosynthetic pathway

Interest in L-glycerol 3-phosphate (L-G3P) production via microbial fermentation is due to the compound's potential to replace the unstable substrate dihydroxyacetone phosphate (DHAP) in one-pot enzymatic carbohydrate syntheses. A Saccharomyces cerevisiae strain with deletions in both genes encoding specific L-G3Pases (GPP1 and GPP2) and multicopy overexpression of L-glycerol 3-phosphate dehydrogenase (GPD1) was studied via small-scale (100 mL) batch fermentations under quasi-anaerobic conditions. Intracellular accumulation of L-G3P reached extremely high levels (roughly 200 mM) but thereafter declined. Extracellular L-G3P was also detected and its concentration continuously increased throughout the fermentation, such that most of the total L-G3P was found outside the cells as fermentation concluded. Moreover, in spite of the complete elimination of specific L-G3Pase activity, the strain showed considerable glycerol formation suggesting unspecific dephosphorylation as a mechanism to relieve cells of intracellular L-G3P accumulation. Up-scaling the process employed fed-batch fermentation with repeated glucose feeding, plus an aerobic growth phase followed by an anaerobic product accumulation phase. This produced a final product titer of about 325 mg total L-G3P per liter of fermentation broth.     

Acquisition of thermotolerant yeast Saccharomyces cerevisiae by breeding via stepwise adaptation

A thermotolerant Saccharomyces cerevisiae yeast strain, YK60‐1, was bred from a parental strain, MT8‐1, via stepwise adaptation. YK60‐1 grew at 40°C, a temperature at which MT8‐1 could not grow at all. YK60‐1 exhibited faster growth than MT8‐1 at 30°C. To investigate the mechanisms how MT8‐1 acquired thermotolerance, DNA microarray analysis was performed. The analysis revealed the induction of stress‐responsive genes such as those encoding heat shock proteins and trehalose biosynthetic enzymes in YK60‐1. Furthermore, nontargeting metabolome analysis showed that YK60‐1 accumulated more trehalose, a metabolite that contributes to stress tolerance in yeast, than MT8‐1. In conclusion, S. cerevisiae MT8‐1 acquired thermotolerance by induction of specific stress‐responsive genes and enhanced intracellular trehalose levels. © 2013 American Institute of Chemical Engineers Biotechnol. Prog., 29:1116–1123, 2013